ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- Operating cash flow, 2025
- $524M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $524M | — |
| 2024 | −$8.3M | — |
| 2023 | $104M | — |
| 2022 | −$541M | — |
| 2021 | −$642M | — |
| 2020 | −$615M | — |
| 2019 | −$278M | — |
| 2018 | −$563M | — |
| 2017 | −$383M | — |
| 2016 | −$308M | — |
| 2015 | −$189M | — |
| 2014 | −$166M | — |
| 2013 | −$69M | — |
| 2012 | −$116M | — |
| 2011 | −$87M | — |
| 2010 | −$84M | — |
| 2009 | −$72M | — |
| 2008 | $65M | — |